Equities Research Analysts’ Price Target Changes for August, 16th (A, AAP, ADSK, BBU, BEP, FFH, IOVA, MESO, PSTI, SGEN)

Equities Research Analysts’ price target changes for Wednesday, August 16th:

Agilent Technologies (NYSE:A) had its price target increased by Janney Montgomery Scott from $65.00 to $70.00. The firm currently has a buy rating on the stock.

Agilent Technologies (NYSE:A) was given a $68.00 price target by analysts at Deutsche Bank AG. The firm currently has a buy rating on the stock.

Advance Auto Parts (NYSE:AAP) was given a $77.00 target price by analysts at Bank of America Corporation. The firm currently has a sell rating on the stock.

Autodesk (NASDAQ:ADSK) had its price target boosted by Robert W. Baird from $110.00 to $120.00. Robert W. Baird currently has an outperform rating on the stock.

Brookfield Business Partners L.P. (NYSE:BBU) had its target price boosted by Brookfield Business Partners LP to $43.00. They currently have an outperform rating on the stock.

Brookfield Renewable Partners L.P. (NYSE:BEP) (TSE:BEP) had its price target increased by Brookfield Renewable Partners LP to $48.50. The firm currently has a buy rating on the stock.

Fairfax Financial Holdings (TSE:FFH) had its target price increased by Fairfax Financial Holdings Ltd. from C$525.00 to C$550.00. Fairfax Financial Holdings Ltd. currently has an outperform rating on the stock.

Lion Biotechnologies (NASDAQ:IOVA) was given a $16.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Mesoblast Limited (NASDAQ:MESO) was given a $14.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Pluristem Therapeutics (NASDAQ:PSTI) was given a $2.00 target price by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Seattle Genetics (NASDAQ:SGEN) was given a $46.00 price target by analysts at Cantor Fitzgerald. The firm currently has a hold rating on the stock.

Theravance Biopharma (NASDAQ:TBPH) was given a $55.00 target price by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

TrovaGene (NASDAQ:TROV) was given a $4.00 target price by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Urban Outfitters (NASDAQ:URBN) was given a $16.00 price target by analysts at MKM Partners. The firm currently has a sell rating on the stock.

Vantiv (NYSE:VNTV) had its price target raised by Oppenheimer Holdings, Inc. from $70.00 to $77.00. The firm currently has an outperform rating on the stock.